AMAG Pharmaceuticals

The company develops and brings treatments to market to help address unmet medical needs for patients.

AMAG appointed Edward (Ted) Myles senior vice president, chief financial officer and treasurer in 2016. Myles was to oversee AMAG’s financial and capital markets activities and its accounting, tax, corporate finance and investor relations teams.

AMAG Pharmaceuticals announced that it would report unaudited consolidated financial results for the first quarter of 2016 before markets opened on May 3, followed by a conference call and webcast with slides.

AMAG Pharmaceuticals announced that its management would participate in the 15th Annual Needham Healthcare Conference in New York City on April 13, 2016, with a corporate update and question-and-answer session.

AMAG’s benefits package includes medical, dental and vision plans, as well as 100% deductible coverage and coinsurance for medical.

Brian Piekos is AMAG’s interim chief financial officer and has held senior management positions at the company since joining in 2015. He has more than 20 years of corporate finance experience and oversees financial planning, reporting, tax, treasury and strategic sourcing.

John Fallon, M.D., has been a director since September 2014. He previously served as senior vice president and chief physician executive at Blue Cross & Blue Shield of Massachusetts and as chief executive officer for clinical affairs at the State University of New York Downstate Medical Center.

Joseph Vittiglio is AMAG’s executive vice president, general counsel, chief business officer and corporate secretary. He previously held legal affairs roles at Flexion Therapeutics, AVEO Pharmaceuticals and Oscient Pharmaceuticals Corporation.

Kelly Schick is AMAG’s senior vice president, chief human resources officer and head of corporate engagement. She joined AMAG in 2016 and has more than 15 years of pharmaceutical human resources experience, including as head of global talent at Bristol-Myers Squibb.

The company prioritizes making effective therapies and support services available to patients and seeks ways to support them throughout their health journeys.

The company develops and brings treatments to market to help address unmet medical needs, and invests in research, education and support services to reduce barriers to care.

Privacy Policy and Cookie Notice (the “Privacy Policy”)

Terms of Use Agreement (the “Terms of Use”)